Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure

NCT03461107 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2019-04-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade in patients with chronic heart failure.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Dao Wen Wang, doctor · Tongji Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-18
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03461107 on ClinicalTrials.gov